Stay updated on CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.

Latest updates to the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe webpage has updated its date listings, adding new dates in April and December 2025 while removing earlier dates from March 2025 and January 2026.SummaryDifference0.8%
- Check23 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes the addition of specific identifiers related to the CTX001 study, while significant details about the study's design and criteria have been removed.SummaryDifference12%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added, indicating a specific change on March 6, 2025. However, the deletion of the date March 25, 2025, suggests that this date is no longer relevant.SummaryDifference0.3%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check59 days agoChange DetectedThe study has been updated to reflect a change in terminology from 'subjects' to 'participants' and has revised the timeline for certain dates related to the study. Additionally, the eligibility criteria and outcome measures have been clarified and updated.SummaryDifference4%
Stay in the know with updates to CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.